A landmark study published in Experimental Neurology demonstrates that Polku Therapeutics' proprietary prolyl oligopeptidase (PREP) ligand prevents long-term memory impairment in a model of repeated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback